slides · global inventory
Chart
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 78,138
Current window 65,071-65,100
Pages 2,605
Rows per page 30
Component
65,071-65,100 of 78,138
07
The slide uses a combination of a biological process diagram and a pharmacokinetic line chart to demonstrate drug synergy.NeuroSense Therapeutics | Investor Presentation Deck | 33 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · Solution1 hit
08
The chart uses hazard ratio as a metric for efficacy in an iPSC model derived from ALS patients.NeuroSense Therapeutics | Investor Presentation Deck | 33 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · Solution1 hit
09
The chart highlights a 'Synchronized concentration peak' at 5 hours for both PrimeC components.NeuroSense Therapeutics | Investor Presentation Deck | 33 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · Solution1 hit
17
The slide highlights a 37.4% reduction in disease progression with statistical significance (p=0.03) in the per-protocol population, while noting a 29% reduction in the ITT analysis.NeuroSense Therapeutics | Investor Presentation Deck | 33 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Before After1 hit
19
The chart visualizes the reduction in points lost, highlighting a 3.22 point difference (p=0.03).NeuroSense Therapeutics | Investor Presentation Deck | 33 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
20
The slide uses a human body diagram to categorize ALS symptoms and bar charts to show the reduction in point loss (slower disease progression) for each category.NeuroSense Therapeutics | Investor Presentation Deck | 33 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · Solution1 hit
21
The chart highlights a 17.2% attenuation in the decline of SVC score for the PrimeC group compared to placebo.NeuroSense Therapeutics | Investor Presentation Deck | 33 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · Solution1 hit
25
The slide presents clinical biomarker data (Aβ40, Aβ42, Tau, pTau, PgJ2) comparing control vs AD groups, analyzed via Mann-Whitney U test.NeuroSense Therapeutics | Investor Presentation Deck | 33 slides · NeuroSense Therapeutics
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
31
The chart shows a clear divergence between the treatment and placebo groups over time, with error bars indicating variability.NeuroSense Therapeutics | Investor Presentation Deck | 33 slides · NeuroSense Therapeutics
Pitch deck Investor relations 1 hit
32
The chart highlights a 13.3% difference at the 180-day mark.NeuroSense Therapeutics | Investor Presentation Deck | 33 slides · NeuroSense Therapeutics
Pitch deck Investor relations 1 hit
10
Includes a patient MRI, a schematic of the PDX study design, a line chart showing tumor volume over time, and photographic evidence of tumor size reduction.Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · Market Size1 hit
18
Includes a biological pathway diagram, microscopy images, and an IC50 dose-response curve.Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
07
The chart tracks subscriber trends for Rent the Runway, highlighting the split between active and paused users over time.Rent The Runway | Results Presentation Deck | 30 slides · Rent The Runway
Conference presentation Investor relations Beat · FinancialsLoop · So What Cascade1 hit
08
The slide includes a note on fiscal year end dates and two key metrics regarding subscriber behavior.Rent The Runway | Results Presentation Deck | 30 slides · Rent The Runway
Conference presentation Investor relations Beat · FinancialsLoop · So What Cascade1 hit
05
The chart uses a rebased share price starting at $0.10.SiriusXM | Investor Presentation Deck | 16 slides · SiriusXM
Conference presentation Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
11
The slide uses a stacked bar chart to illustrate the discrepancy between population size and audio spend, segmenting the audience into 'Core' and 'Growth'.SiriusXM | Investor Presentation Deck | 20 slides · SiriusXM
Conference presentation Investor relations Beat · Market Size1 hit
07
The chart is a stacked bar chart showing the composition of bookings over time.Skillsoft | Results Presentation Deck | 15 slides · Skillsoft
Conference presentation Investor relations Beat · KPI OverviewLoop · Zoom In1 hit
08
The chart shows a stacked bar comparison of revenue across six quarters (Q1 '23 to Q3 '24).Skillsoft | Results Presentation Deck | 15 slides · Skillsoft
Conference presentation Investor relations Beat · KPI OverviewLoop · Zoom In1 hit
09
Skillsoft | Results Presentation Deck | 15 slidesSkillsoft | Results Presentation Deck | 15 slides · Skillsoft
Conference presentation Investor relations Beat · KPI OverviewLoop · Zoom In1 hit
12
The slide uses a bar-chart-like visualization to show market growth and lists drivers for expansion.Vivid Seats | Investor Presentation Deck | 24 slides · Vivid Seats
Pitch deck Investor relations Beat · Market SizeLoop · Golden Circle1 hit
18
2020 data is omitted due to COVID-19.Vivid Seats | Investor Presentation Deck | 24 slides · Vivid Seats
Pitch deck Investor relations Loop · Golden Circle1 hit
11
The slide uses pie charts to represent the relative weight of categories within each brand's portfolio.Zegna | Investor Day Presentation Deck | 150 slides · Zegna
Conference presentation Investor relations Beat · Need1 hit
13
The chart uses a concentric arc diagram to represent market size segments, mapping brands to these segments.Zegna | Investor Day Presentation Deck | 150 slides · Zegna
Conference presentation Investor relations Beat · Need1 hit
14
Uses a custom framework to visualize synergy impact vs. assessment phase for four business functions.Zegna | Investor Day Presentation Deck | 150 slides · Zegna
Conference presentation Investor relations Beat · Need1 hit
40
The slide uses a visual comparison of men's vs women's product categories and gender mix percentages to identify a gap in the women's accessories segment.Zegna | Investor Day Presentation Deck | 150 slides · Zegna
Conference presentation Investor relations Beat · Action1 hit
63
Zegna | Investor Day Presentation Deck | 150 slidesZegna | Investor Day Presentation Deck | 150 slides · Zegna
Conference presentation Investor relations Beat · Action1 hit
81
The chart shows a clear trend of increasing DTC store count while wholesale store count remains relatively flat or decreases as a proportion of the total.Zegna | Investor Day Presentation Deck | 150 slides · Zegna
Conference presentation Investor relations Beat · Action1 hit
103
The slide uses a Venn diagram to show brand consolidation and a perceptual map to show competitive positioning.Zegna | Investor Day Presentation Deck | 150 slides · Zegna
Conference presentation Investor relations Beat · Action1 hit
104
Uses a waterfall-style arrow to show SKU reduction and a process arrow to show product line consolidation.Zegna | Investor Day Presentation Deck | 150 slides · Zegna
Conference presentation Investor relations Beat · Action1 hit
106
The slide illustrates a strategic shift towards a direct-to-consumer retail model.Zegna | Investor Day Presentation Deck | 150 slides · Zegna
Conference presentation Investor relations Beat · Action1 hit